PTEN Enzyme, active is a N-Terminal GST-Tagged, recombinant human PTEN (Phosphatase and Tensin Homolog), 76kD, purified from E.coli using glutathione-sepharose column chromatography.
Storage: Store product > -70 oC. Enzyme is stable for at least 6 months at -70 oC as undiluted stockSpecificity: PTEN selectively removes phosphate from the 3’ position of the inositol ring of PtdIns(3,4,5)P3Specific Activity: request Certificate of Analysis (COA)
The PTEN enzyme is a 3-phosphoinositide phosphatase that converts PI(3,4,5)P3 to PI(4,5)P2; thus opposing PKB/Akt activation by PI3-K. PTEN is involved in neuronal stem cell proliferation and self-renewal, cardiac myocyte hypertrophy and contractility, and a wide range of developmental processes. PTEN, however, is best known for its role as a tumor suppressor. Loss of PTEN activity results in accumulation of PI(3,4,5)P3, abnormal activation of PKB/Akt, unregulated cell growth, suppression of apoptosis, and increase tumorigenesis in a number of human tissues. It has also been proposed that PTEN is a candidate for targeted chemotherapy because certain anti-cancer agents preferentially destroy tumors with PTEN mutations. In addition to this direct role in cancer, PTEN also indirectly regulates cancer-associated pathways including VEGF-mediated angiogenesis among others.
Publications
Powered by Bioz See more details on Bioz
1. Brooks, R., et al. (2010). “SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells.” J Immunol 184(7): 3582-3589.2. Caromile, L. A., et al. (2010). “The neurosecretory vesicle protein phogrin functions as a phosphatidylinositol phosphatase to regulate insulin secretion.” J Biol Chem 285(14): 10487-10496.3. Thakral, C., et al. (2012). “ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/akt activity with retained but inactivated PTEN—A report from the Children’s Oncology Group.” Pediatric Blood & Cancer 59(3): 440-447.4. Steidle, E. A., et al. (2016). “A novel inositol pyrophosphate phosphatase in Saccharomyces cerevisiae: Siw14 selectively cleaves the b-phosphate from 5-diphosphoinositol pentakisphosphate (5PP-IP5).” J. Biol. Chem. 291: 6772-6783.5. Alsina-Sanchís, E., et al. (2018). “ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.” Arteriosclerosis, thrombosis, and vascular biology 38(5): 1216-1229.